Ali Shakir, MD
Clinical Cardiac Electrophysiology · Roseville, MINPI 1477754323
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $58,500 of the $81,951 with a category attached, or 71.4%. ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) accounts for 72.9% of it on its own, with 32 other manufacturers making up the rest.
Across 341 payments — averaging $240.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$60K
- Medtronic$11K
- Boston Scientific$9K
- Biosense Webster, Inc.$339
- Abbott$265
- Johnson & Johnson$215
- plus $1K from 27 others
Across 33 payments — averaging $2629.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$85K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$2K
What the payments were for
- Speaking & faculty fees$58,50071%
- Travel & lodging$12,37515%
- Food & beverage$11,00613%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 97 | $59,706 |
| Medtronic(2 entities) | 89 | $11,155 |
| Boston Scientific | 57 | $8,813 |
| Biosense Webster, Inc. | 3 | $339 |
| Abbott | 7 | $265 |
| Johnson & Johnson | 15 | $215 |
| Novartis | 9 | $158 |
| Amgen | 9 | $152 |
| Boehringer Ingelheim | 6 | $118 |
| Philips North America LLC | 6 | $104 |
| Irhythm Technologies, Inc. | 4 | $88 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $68 |
| Biotronik Inc. | 3 | $66 |
| Impulse Dynamics (USA) Inc. | 2 | $63 |
| Cordis US CORP. | 2 | $61 |
| Kestra Medical Technology Services, Inc. | 2 | $60 |
| Pfizer | 3 | $55 |
| Heartflow, Inc. | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Cardiva Medical, Inc. | 1 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Atricure, Inc. | 2 | $36 |
| Amarin Pharma, Inc. | 2 | $32 |
| Braemar Manufacturing, LLC | 1 | $31 |
| AstraZeneca | 2 | $30 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $30 |
| Portola Pharmaceuticals, LLC | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 2 | $28 |
| Chiesi USA, Inc. | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Edwards Lifesciences | 1 | $16 |
| Angiodynamics, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$58,119
- Farapulse$3,022
- Arctic Front$1,451
- GENERAL - THERAPIES$1,218
- ARCTIC FRONT ADVANCE$692
- LUX-Dx Insertable Cardiac Monitor$320
- Carto 3$150
- EMBLEM MRI S-ICD$147
- WATCHMAN Access System$144
- QDOT MICRO Catheter$142
- Micra$133
- CARDIOMEMS$125
How this compares
$81,951 in reported general payments places this provider in the 85th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
See all clinical cardiac electrophysiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 144 | $163,069 |
| XareltoRivaroxaban | 98 | $117,713 |
| EntrestoSacubitril/Valsartan | 21 | $13,916 |
| Metoprolol Succinate | 380 | $7,921 |
| Propafenone Hcl | 47 | $3,933 |
| Mexiletine Hcl | 16 | $2,566 |
| SotalolSotalol Hcl | 78 | $1,700 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 60 | $1,605 |
| Diltiazem Hcl | 17 | $1,195 |
| Amiodarone Hcl | 37 | $1,065 |
| Digoxin | 34 | $1,001 |
| Flecainide Acetate | 23 | $985 |
| Metoprolol Tartrate | 66 | $730 |
| Nifedipine ErNifedipine | 16 | $614 |
| Carvedilol | 29 | $282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $55 | $163,069144 claims |
| Johnson & JohnsonXarelto | $215 | $117,71398 claims |
| NovartisEntresto | $158 | $13,91621 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
Other clinical cardiac electrophysiology in Roseville
- Salem SayarRoseville$16K
- Randy LiebermanDetroit$1.2M
- Asim YunusSaginaw$236K
- Jackson LiangAnn Arbor$229K
- Ryan CunnaneAnn Arbor$218K
- Dipak ShahSouthfield$194K
- Rakesh LatchamsettyBrighton$165K
- Ilana KutinskyTroy$138K
- Nishaki MehtaRoyal Oak$133K
- Andre GauriGrand Rapids$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.